search
CSL
Trends
- 1CSL Limited share price draws investor attention▼CSL Limited (CSL.AX) stock price, news, quote and history
Australian biotechnology company CSL Limited is being tracked by investors looking up its share price, quotes and market history on financial data platforms. The Melbourne-based blood products and vaccines maker is one of Australia's largest listed companies, and its stock is a regular focus for traders following healthcare sector moves and earnings news. No specific price movement or announcement is given.
- 2CSL and Alentis sign $1.6bn deal for rare kidney and liver diseases●CSL and Alentis strike $1.6bn collab for rare kidney and liver diseases
Australian biotech giant CSL and Swiss-based Alentis Therapeutics have announced a collaboration worth up to $1.6 billion to develop treatments for rare kidney and liver diseases. The partnership will combine Alentis's antibody-drug conjugate platform with CSL's development and commercialisation resources, aiming to bring new therapies to patients with limited treatment options.